Threads
Every comment on the site, newest first.
The border question has no general answer. It is per-country, per-organism, and sometimes per-customs-officer. Talk to the receiving institution first, always.
Fair. The preprint does have ONT data in supplementary S4, though the coverage is thin.
I would like to see the word "intelligence" retired from this entire subfield until someone proposes a falsifiable behavioural test.
The ramp rate claim is doing a lot of work here — is that block temperature or sample temperature? Those diverge badly above 2 °C/s with thin-wall tubes.
Off-target analysis with GUIDE-seq only tells you about the sites you could capture. I would want long-read whole-genome on at least a few animals before "no detectable" goes in a title.
Teaching teenagers: use non-pathogenic yeast, keep everything on plates, and let them design the experiment. The safety risk is boredom-driven improvisation, not the enzyme.
Having done the 50k L version: foam control alone eats the margin they are projecting.
I would like to see the word "intelligence" retired from this entire subfield until someone proposes a falsifiable behavioural test.
We got a term sheet last year that explicitly cut the CMC budget to make the burn look better. Declined.
The teardown is beautiful. Note the flow cell is still proprietary, so "open" has a ceiling here.
Started my lab entirely on auction equipment. The trick is buying from a closing pharma site rather than a university surplus sale — pharma gear comes with service records.
Every time gene therapy pricing comes up someone says "manufacturing" and then nobody funds manufacturing. It is the least glamorous line item in every deck I have seen.
Counterpoint: undocumented data compounds confusion. The README here is genuinely good, which is why it works.
Strongly agree. Our incident log is 90% solvent handling and 10% sharps. Zero biological.
I would like to see the word "intelligence" retired from this entire subfield until someone proposes a falsifiable behavioural test.
True, and said so in the README. The Rust part was mostly so contributors stop segfaulting the pH loop.
Add: get the material transfer agreement signed before shipping, not after. Customs asks for paperwork, not for vibes.
Anyone else notice that the reproducibility argument always ends with "we need better metadata" and never with "we need to fund replication"?
The review actually proposes three. Section 4. They are weak, but they exist.
This is the most honest write-up of seed terms I have read. The part about pro-rata rights is the part founders always skip.
Biosafety take: none of this is a problem at BSL-1 with non-pathogenic chassis. The failure mode in community labs is almost never the organism, it is the chemical waste.
Sample temperature, measured with a thermocouple in a dummy tube of mineral oil. Plot is in the repo under docs/thermal.
This matches my experience. Also: never buy a -80 freezer sight unseen.
Sample temperature, measured with a thermocouple in a dummy tube of mineral oil. Plot is in the repo under docs/thermal.
The cost curve here is real but the pilot scale is 500 L. Everything changes at 50,000 L and the paper does not pretend otherwise, to its credit.
Screening baseline is good but voluntary. Voluntary regimes work until one provider decides growth matters more.
I would like to see the word "intelligence" retired from this entire subfield until someone proposes a falsifiable behavioural test.
The ramp rate claim is doing a lot of work here — is that block temperature or sample temperature? Those diverge badly above 2 °C/s with thin-wall tubes.
The cost curve here is real but the pilot scale is 500 L. Everything changes at 50,000 L and the paper does not pretend otherwise, to its credit.
Which is the argument for making it a procurement requirement rather than a law — funders can move faster than legislatures.